Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anhydrate-free polymorphically pure micronized crystalline brexpiprazole di-hydrate for use in intramuscular injectable sustained release formulations

Anhydrate-free polymorphically pure micronized crystalline brexpiprazole di-hydrate for use in intramuscular injectable sustained release formulations

US Patent 10501450 · Granted Dec 10, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Co-crystal of an orally available HIF prolyl hydroxylase inhibitor2021
Crystalline eravacycline bis-hydrochloride2021
Crystalline forms of valbenazine salts2021
Crystalline valbenazine free base2020
Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-2019
Form C of avibactam sodium2019
Preparation of ertapenem intermediates2017
Crystalline forms of ceftaroline fosamil2017
Crystal forms of saxagliptin2016
Method of preparing polymorphic pure form A of bazedoxifene acetate2015
Polymorphs of an active pharmaceutical ingredient2015
Pharmaceutical compositions containing a crystalline form of posaconazole2013